FR2265354A1 - Medicaments for treating radiation sickness - contg. glycoprotein and lipoprotein complexes, kallikrein inhibitor, thiamine diphosphate, tryptophan and arginine - Google Patents
Medicaments for treating radiation sickness - contg. glycoprotein and lipoprotein complexes, kallikrein inhibitor, thiamine diphosphate, tryptophan and arginineInfo
- Publication number
- FR2265354A1 FR2265354A1 FR7410326A FR7410326A FR2265354A1 FR 2265354 A1 FR2265354 A1 FR 2265354A1 FR 7410326 A FR7410326 A FR 7410326A FR 7410326 A FR7410326 A FR 7410326A FR 2265354 A1 FR2265354 A1 FR 2265354A1
- Authority
- FR
- France
- Prior art keywords
- medicaments
- tryptophan
- arginine
- glycoprotein
- kallikrein inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 230000005855 radiation Effects 0.000 title abstract 3
- 101000975003 Homo sapiens Kallistatin Proteins 0.000 title abstract 2
- 101001077723 Homo sapiens Serine protease inhibitor Kazal-type 6 Proteins 0.000 title abstract 2
- 102100023012 Kallistatin Human genes 0.000 title abstract 2
- 102000004895 Lipoproteins Human genes 0.000 title abstract 2
- 108090001030 Lipoproteins Proteins 0.000 title abstract 2
- 206010025482 malaise Diseases 0.000 title abstract 2
- 235000008170 thiamine pyrophosphate Nutrition 0.000 title abstract 2
- 239000011678 thiamine pyrophosphate Substances 0.000 title abstract 2
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 title abstract 2
- 239000004475 Arginine Substances 0.000 title 1
- 102000003886 Glycoproteins Human genes 0.000 title 1
- 108090000288 Glycoproteins Proteins 0.000 title 1
- 229940122920 Kallikrein inhibitor Drugs 0.000 title 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 title 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 title 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title 1
- 208000017667 Chronic Disease Diseases 0.000 abstract 1
- 208000032843 Hemorrhage Diseases 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- 229930064664 L-arginine Natural products 0.000 abstract 1
- 235000014852 L-arginine Nutrition 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 210000001185 bone marrow Anatomy 0.000 abstract 1
- 230000001627 detrimental effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002285 radioactive effect Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 229960004799 tryptophan Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7410326A FR2265354A1 (en) | 1974-03-26 | 1974-03-26 | Medicaments for treating radiation sickness - contg. glycoprotein and lipoprotein complexes, kallikrein inhibitor, thiamine diphosphate, tryptophan and arginine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7410326A FR2265354A1 (en) | 1974-03-26 | 1974-03-26 | Medicaments for treating radiation sickness - contg. glycoprotein and lipoprotein complexes, kallikrein inhibitor, thiamine diphosphate, tryptophan and arginine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2265354A1 true FR2265354A1 (en) | 1975-10-24 |
| FR2265354B1 FR2265354B1 (enExample) | 1977-11-04 |
Family
ID=9136819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7410326A Granted FR2265354A1 (en) | 1974-03-26 | 1974-03-26 | Medicaments for treating radiation sickness - contg. glycoprotein and lipoprotein complexes, kallikrein inhibitor, thiamine diphosphate, tryptophan and arginine |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2265354A1 (enExample) |
-
1974
- 1974-03-26 FR FR7410326A patent/FR2265354A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2265354B1 (enExample) | 1977-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199901132T2 (xx) | N-(aril/heteoaril) amino asit t�revleri, bunlar� i�eren farmas�tik bile�imler ve b�yle bile�ikler kullan�larak �-amiloid peptidinin sal�nmas�n� ve/veya sentezini inhibe etmek i�in y�ntemler. | |
| ATE254926T1 (de) | Verwendung eines consensus-interferons zur reduzierung der nebeneffekte in der interferon behandlung von viralen hepatiten. | |
| DE69621012D1 (de) | VERWENDUNG VON NSAIDs ZUR BEHANDLUNG VON PLATTENEPITHELKARZINOM DER MUNDHÖHLE UND KEHLKOPF | |
| ES2032382T3 (es) | Metodo para preparar un medicamento para la prevencion o tratamiento de la endometriosis. | |
| ATE187646T1 (de) | Verwendung von kupfer enthaltenden wirkstoffen zur beschleunigung der wundheilung | |
| DK108083A (da) | Dipeptidsoedemiddel-metal-kompleks og dets anvendelse | |
| DE3866045D1 (de) | Arzneimittel zur behandlung von uraemie. | |
| ES438931A1 (es) | Procedimiento para la preparacion de nuevos derivados de amino-3 hidroxi-2 fenoxi-1 propano. | |
| ES441788A1 (es) | Procedimiento para la obtencion de derivadas de depeptidos. | |
| DE69130063D1 (de) | Antivirales arzneimittel enthaltend prostratin | |
| FR2265354A1 (en) | Medicaments for treating radiation sickness - contg. glycoprotein and lipoprotein complexes, kallikrein inhibitor, thiamine diphosphate, tryptophan and arginine | |
| NL7403637A (en) | Medicaments for treating radiation sickness - contg. glycoprotein and lipoprotein complexes, kallikrein inhibitor, thiamine diphosphate, tryptophan and arginine | |
| ATE76579T1 (de) | Interferon-zusammensetzungen. | |
| CH505056A (de) | Verfahren zur Herstellung von L-3-(3',4'-Dihydroxyphenyl)-alanin | |
| RU94040886A (ru) | Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция | |
| EG10508A (en) | Method for preparation of 5-aryl 2,3-dihydro-2,2(or 3,3)dimethyl-5h-imidazo(2,1-a)isoindol-5-ols and 2(4,4(5,5)dimethyl-2-imidazolin-2-yl)bensophenone acid addition salts used as autidepressant drug | |
| NL178416C (nl) | Werkwijze voor de bereiding van een stabilisator op basis van 2,2'-methyleen-bis-(4,6-dialkylfenol) en toepassing van deze produkten bij de stabilisatie van polyalkenen. | |
| FR2059975A1 (en) | 1-substd cyclohexane carboxylic acid hydrazides | |
| SE8403659D0 (sv) | Synergistic pharmaceutical composition | |
| GB1270049A (en) | New pharmaceutical product | |
| Chang | Clinical aspects of hyperbaric oxygen and radiotherapy | |
| DE3484329D1 (de) | Verwendung von gamma-interferon zur herstellung eines wirkstoffes in der behandlung von lepra. | |
| FR2196791A1 (en) | L-Arginine N-acetyl-DL-methioninate - as liver protective agent and for treating ammonaemia | |
| FR2113947A1 (en) | Oral raubasine compositions - also contg polyethylene glycol to improve resorption | |
| DE3879837D1 (de) | Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |